Atlas Trials

A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).

Clinical trial NCT06029452 · COMPLETED

Trial details

NCT number
NCT06029452
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
ATTR-CM
Start date
2023-09-01
Primary completion
2023-11-14
Enrollment
558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.